Corteva’s Vylor Spin-off: Biotech’s 2027 Blueprint?
Corteva spun off Vylor, its gene-editing unit. See why this move could reshape biotech innovation and accelerate climate-resilient crop development.
Corteva spun off Vylor, its gene-editing unit. See why this move could reshape biotech innovation and accelerate climate-resilient crop development.
Can blockchain truly secure digital trust by 2026? Learn how immutable records and decentralized identity boost cyber resilience.
CRISPR is reshaping agriculture. See how gene-edited crops drive a projected $1.5 billion market by 2028, impacting food and trade.
Corteva launches CRISPR maize by 2027. Will gene-edited crops feed the future? Understand the tech, regulation, and public perception.
CRISPR gene editing addresses global food challenges. See how precision crop modification speeds disease resistance, boosts nutrition. What's next for 2027?
Can AI protect 2026 elections from disinformation? See how AI fights deepfakes and fraud, and why public education is key to a 70% reduction in spread.
New maize diseases threaten global crops. See how genetic engineering and IPM offer hope for farmers like John Albright against rising pathogens.
Microsoft Power Platform's 2026 update adds generative AI to Power Apps, Automate, and BI. See key features & why they matter for business automation.
CRISPR patent disputes could limit access to gene-edited crops. Learn why these legal battles impact future food security and developing nations.
CRISPR maize could secure 2026 food supplies. Learn how gene-editing fights crop disease, reduces pesticides, and impacts global food security.